Thiazolidinedione Use Is Associated with a Borderline Lower Risk of Multiple Myeloma and a Significantly Lower Risk of Death in Patients with Type 2 Diabetes Mellitus in Taiwan.

Cancers (Basel) · 2023 · PMC10486533 · PMID 37686552

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

borderline significantno p-value reported

Although the benefit of TZD on MM risk was borderline significant ( Table 2 ), patients who had been treated with TZD might have a significantly lower risk of death ( Figure 2 ). 4.2.

also in 11,409 other papers

borderline significanceno p-value reported

The findings suggest a 35% lower risk of multiple myeloma associated with TZD with borderline significance.

also in 7,017 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.